Michael E Raizner, MD in Sugar Land, TX - Medicare Cardiovascular Disease (cardiology)

Michael E Raizner, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in Sugar Land, Texas. He went to Baylor College Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Interventional Cardiology Associates and his current practice location is 16659 Southwest Fwy, Ste 215, Sugar Land, Texas. You can reach out to his office (for appointments etc.) via phone at (281) 265-2393.

Michael E Raizner is licensed to practice in Texas (license number L5105) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1417931155.

Contact Information

	Michael E Raizner, MD
	16659 Southwest Fwy, Ste 215, Sugar Land, TX 77479-2375
	(281) 265-2393
	(281) 265-2341

Physician's Profile

Full Name	Michael E Raizner
Gender	Male
Speciality	Cardiovascular Disease (cardiology)
Experience	26 Years
Location	16659 Southwest Fwy, Sugar Land, Texas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Michael E Raizner attended and graduated from Baylor College Of Medicine in 1998

NPI Data:

NPI Number: 1417931155
Provider Enumeration Date: 12/06/2005
Last Update Date: 06/26/2008

Medicare PECOS Information:

PECOS PAC ID: 3476599531
Enrollment ID: I20050629000814

Medical Identifiers

Medical identifiers for Michael E Raizner such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417931155	NPI	-	NPPES
173964101	Medicaid	TX
173964102	Medicaid	TX

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RC0000X	Internal Medicine - Cardiovascular Disease	L5105 (Texas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Houston Methodist Hospital	Houston, TX	Hospital
Houston Methodist Sugarland Hospital	Sugar land, TX	Hospital
El Campo Memorial Hospital	El campo, TX	Hospital
Houston Methodist St John Hospital	Nassau bay, TX	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Interventional Cardiology Associates	1456334861	5

News Archive

OIE, WHO release new global framework to eliminate dog-mediated human rabies

In accordance with the consensus of the Global Conference held in Geneva on 10-11 December 2015, the World Organisation for Animal Health and the World Health Organization are releasing their global framework for the elimination of dog-mediated human rabies, in collaboration with the Food and Agriculture Organization of the United Nations and with the support of the Global Alliance for Rabies Control.

Better understanding of new T-size descriptors on adjuvant chemotherapy effect needed

The most recent research released in June's Journal of Thoracic Oncology indicates there might be a positive correlation between tumor size and adjuvant platinum based chemotherapy in surgically resected patients with node negative non-small cell lung cancer.

Study shows strong link between adolescent obesity and high blood pressure

A recent study published in the American Journal of Hypertension has found that body mass index (BMI) in healthy adolescents has a statistically significant association with both systolic blood pressures (SBP) and diastolic blood pressures (DBP), and highlights the significance of the global trend of rapidly increasing adolescent obesity.

Rexahn's quinoxalinyl-piperazine compounds receive U.S. patent

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."

University of Florida researchers restore vitality to cells in lab experiments

University of Florida researchers say primitive cells that act like molecular maintenance men - traveling throughout the body to repair damaged blood vessels - become too rigid to move in patients with diabetes, fueling the disease's vascular complications.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael E Raizner allows following entities to bill medicare on his behalf.

Entity Name	Interventional Cardiology Associates
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1710070875 PECOS PAC ID: 1456334861 Enrollment ID: O20040608000743

News Archive

OIE, WHO release new global framework to eliminate dog-mediated human rabies

Better understanding of new T-size descriptors on adjuvant chemotherapy effect needed

Study shows strong link between adolescent obesity and high blood pressure

Rexahn's quinoxalinyl-piperazine compounds receive U.S. patent

University of Florida researchers restore vitality to cells in lab experiments

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael E Raizner is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael E Raizner, MD 6550 Fannin St, Ste 2021, Houston, TX 77030-2717 Ph: (713) 790-9125	Michael E Raizner, MD 16659 Southwest Fwy, Ste 215, Sugar Land, TX 77479-2375 Ph: (281) 265-2393

News Archive

OIE, WHO release new global framework to eliminate dog-mediated human rabies

Better understanding of new T-size descriptors on adjuvant chemotherapy effect needed

Study shows strong link between adolescent obesity and high blood pressure

Rexahn's quinoxalinyl-piperazine compounds receive U.S. patent

University of Florida researchers restore vitality to cells in lab experiments

Internal Medicine Doctors in Sugar Land, TX

Vandana Khera, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18717 University Blvd Bldg 2, Suite 105, Sugar Land, TX 77479 Phone: 281-208-3322 Fax: 281-208-3393
Susan Vijayan Mathew, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16811 Southwest Fwy Fl 3, Sugar Land, TX 77479 Phone: 281-275-0897
Saif K Altaie, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Fwy, Sugar Land, TX 77479 Phone: 281-274-7000
Priya N. Oolut, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16659 Southwest Fwy Ste 421, Sugar Land, TX 77479 Phone: 281-325-0005 Fax: 713-512-2247
Dr. Htut Kyaw Win, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy Ste 360, Sugar Land, TX 77479 Phone: 713-790-0841 Fax: 713-790-9963
Cathlyn Anderson, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 15200 S Us 59 Highway Suite 360, Sugar Land, TX 75075 Phone: 832-237-3500 Fax: 832-237-0200
Angela Denise Mcgee, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11555 University Blvd, Sugar Land, TX 77478 Phone: 713-442-9100

Michael E Raizner, MD - Medicare Cardiovascular Disease (cardiology) in Sugar Land, TX

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

OIE, WHO release new global framework to eliminate dog-mediated human rabies

Better understanding of new T-size descriptors on adjuvant chemotherapy effect needed

Study shows strong link between adolescent obesity and high blood pressure

Rexahn's quinoxalinyl-piperazine compounds receive U.S. patent

University of Florida researchers restore vitality to cells in lab experiments

Medicare Reassignments

OIE, WHO release new global framework to eliminate dog-mediated human rabies

Better understanding of new T-size descriptors on adjuvant chemotherapy effect needed

Study shows strong link between adolescent obesity and high blood pressure

Rexahn's quinoxalinyl-piperazine compounds receive U.S. patent

University of Florida researchers restore vitality to cells in lab experiments

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

OIE, WHO release new global framework to eliminate dog-mediated human rabies

Better understanding of new T-size descriptors on adjuvant chemotherapy effect needed

Study shows strong link between adolescent obesity and high blood pressure

Rexahn's quinoxalinyl-piperazine compounds receive U.S. patent

University of Florida researchers restore vitality to cells in lab experiments

Internal Medicine Doctors in Sugar Land, TX